Notice: This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends AMDA vs. QIPT, SRTS, TLSI, TELA, GUTS, MGRM, LNSR, NSPR, WOK, and APYXShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include Quipt Home Medical (QIPT), Sensus Healthcare (SRTS), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), LENSAR (LNSR), InspireMD (NSPR), WORK Medical Technology Group LTD Ordinary Shares (WOK), and Apyx Medical (APYX). These companies are all part of the "medical" sector. Amedica vs. Quipt Home Medical Sensus Healthcare TriSalus Life Sciences TELA Bio Fractyl Health Monogram Orthopaedics LENSAR InspireMD WORK Medical Technology Group LTD Ordinary Shares Apyx Medical Quipt Home Medical (NASDAQ:QIPT) and Amedica (NASDAQ:AMDA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations. Which has preferable valuation and earnings, QIPT or AMDA? Quipt Home Medical has higher revenue and earnings than Amedica. Quipt Home Medical is trading at a lower price-to-earnings ratio than Amedica, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuipt Home Medical$245.92M0.44-$2.78M-$0.15-16.60Amedica$11.23M3.72-$9.32M-$3.13-1.12 Do institutionals & insiders believe in QIPT or AMDA? 42.8% of Quipt Home Medical shares are held by institutional investors. Comparatively, 3.7% of Amedica shares are held by institutional investors. 4.2% of Quipt Home Medical shares are held by insiders. Comparatively, 0.9% of Amedica shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend QIPT or AMDA? Quipt Home Medical presently has a consensus target price of $6.25, indicating a potential upside of 151.00%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Quipt Home Medical is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quipt Home Medical 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to QIPT or AMDA? In the previous week, Quipt Home Medical had 15 more articles in the media than Amedica. MarketBeat recorded 15 mentions for Quipt Home Medical and 0 mentions for Amedica. Quipt Home Medical's average media sentiment score of 0.03 beat Amedica's score of 0.00 indicating that Quipt Home Medical is being referred to more favorably in the media. Company Overall Sentiment Quipt Home Medical Neutral Amedica Neutral Is QIPT or AMDA more profitable? Quipt Home Medical has a net margin of -1.95% compared to Amedica's net margin of -139.62%. Quipt Home Medical's return on equity of -4.51% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Quipt Home Medical-1.95% -4.51% -2.01% Amedica -139.62%-148.60%-67.83% Does the MarketBeat Community prefer QIPT or AMDA? Amedica received 276 more outperform votes than Quipt Home Medical when rated by MarketBeat users. However, 83.78% of users gave Quipt Home Medical an outperform vote while only 64.90% of users gave Amedica an outperform vote. CompanyUnderperformOutperformQuipt Home MedicalOutperform Votes3183.78% Underperform Votes616.22%AmedicaOutperform Votes30764.90% Underperform Votes16635.10% Which has more volatility and risk, QIPT or AMDA? Quipt Home Medical has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Amedica has a beta of -1.24, indicating that its share price is 224% less volatile than the S&P 500. SummaryQuipt Home Medical beats Amedica on 16 of the 19 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.78M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-1.1225.0190.0517.18Price / Sales3.7245.901,116.25117.06Price / CashN/A43.4443.1037.85Price / Book1.967.094.784.78Net Income-$9.32M$13.64M$120.31M$225.60M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$3.52-3.8%N/A+848.5%$41.78M$11.23M-1.12N/AGap DownQIPTQuipt Home Medical2.5482 of 5 stars$3.07+2.0%$6.25+103.6%-51.7%$132.29M$221.74M-27.361,200Earnings ReportAnalyst RevisionNews CoverageSRTSSensus Healthcare3.7704 of 5 stars$7.97-2.3%$12.50+56.8%+177.3%$130.63M$24.41M14.3240Positive NewsTLSITriSalus Life Sciences4.02 of 5 stars$3.88-0.8%$12.08+211.4%-49.7%$118.31M$26.89M-1.57106Analyst ForecastInsider TradeNews CoveragePositive NewsGap UpTELATELA Bio2.9878 of 5 stars$2.79+0.7%$9.25+231.5%-53.6%$109.90M$58.45M-1.64120GUTSFractyl Health0.8734 of 5 stars$2.11+3.4%$22.00+942.7%N/A$101.49M$120,000.00-0.17102MGRMMonogram Orthopaedics3.2283 of 5 stars$2.76+3.8%$4.00+44.9%-23.1%$94.70M$364,999.00-5.6628LNSRLENSAR0.5735 of 5 stars$7.34-2.8%$8.00+9.0%+174.0%$85.25M$48.87M-5.17110News CoverageHigh Trading VolumeNSPRInspireMD2.1916 of 5 stars$2.90-1.7%$4.75+63.8%+45.6%$75.64M$6.82M-3.9350Analyst ForecastGap UpWOKWORK Medical Technology Group LTD Ordinary SharesN/A$5.09-6.8%N/AN/A$73.81MN/A0.00226Gap UpHigh Trading VolumeAPYXApyx Medical1.6476 of 5 stars$1.68flatN/A-37.5%$63.24M$48.54M-2.02270Positive News Related Companies and Tools Related Companies Quipt Home Medical Competitors Sensus Healthcare Competitors TriSalus Life Sciences Competitors TELA Bio Competitors Fractyl Health Competitors Monogram Orthopaedics Competitors LENSAR Competitors InspireMD Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors Apyx Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AMDA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
